Perspective Therapeutics, Inc. (CATX)
4.71
-0.31
(-6.18%)
USD |
NYAM |
Feb 13, 16:00
4.82
+0.11
(+2.34%)
After-Hours: 17:32
Perspective Therapeutics Cash from Investing (Quarterly) : 13.99M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -- |
| Accuray, Inc. | -- |
| Alphatec Holdings, Inc. | -13.89M |
| Boston Scientific Corp. | -- |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.29M |
| Cash from Financing (Quarterly) | 0.213M |
| Free Cash Flow | -106.85M |
| Free Cash Flow Per Share (Quarterly) | -0.2466 |
| Free Cash Flow to Equity (Quarterly) | -18.07M |
| Free Cash Flow to Firm (Quarterly) | -18.26M |
| Free Cash Flow Yield | -31.12% |